News
.png)
Dr. Paul Billings Joins Lindus Health's Scientific Advisory Board
Lindus Health has announced the appointment of Dr. Paul Billings to its Scientific Advisory Board, strengthening its expertise in diagnostic and genomic medicine. A recognized leader in diagnostics with decades of experience across industry and clinical research, Dr. Billings will help guide Lindus Health’s strategy for designing and executing high-quality diagnostic clinical trials, supporting faster, more reliable paths from diagnostic innovation to patient impact.
Why I Joined Lindus Health - Emma Ogburn PhD, VP Clinical Operations
To work on innovative trials and accelerate access to treatments. To tackle disparities in research accessibility. To use technology to accelerate studies and work with a motivated team. Hear more from our VP of Clinical Operations, Emma Ogburn PhD, on why she joined Lindus Health.
%2520(1).jpeg)
Why I joined Lindus Health? Van Zyl Engelbrecht
The mission to accelerate clinical trial. The focus on making clinical research more patient-centric. The ability to support innovative health companies bring their product to market at a lower cost.
Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies In the Space to Streamline Clinical Trials
We're introducing our All-In-One CRO solution for the digital therapeutics market.
Interview: Robert Langer backs Lindus Health’s "anti-CRO" strategy
Robert Langer and Lindus Health co-founder, Meri Beckwith, sat down for a Q&A session to discuss their new partnership and future direction of the company.
.png)
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
We are thrilled to announce Robert S. Langer, co-founder of Moderna, has joined our advisory board.
Being Nimble and Tech-Forward in Clinical Trial Operations
In our latest fireside chat, we sat down with Dan Gusz, Chief of Staff at Signos, to discuss some of the common challenges sponsors see when collaborating with CROs along with the benefits of being cutting-edge in technology when approaching clinical trials.
Lindus Health and Thirty Madison complete enrollment of personalized dermatology care pilot study
We're excited to announce the completion of enrollment in Thirty Madison's personalized dermatology care pilot study that we're delivering.
Product Clinic #9: Bringing about the right kind of change with AI
Amiel Kollek, senior software engineer at Lindus Health, reflects on the use of AI in clinical trials and how it can be used to bring about the right kind of change.
Drug Discovery is Becoming More $$$ — Here's Why, And How We're Fixing IT
Drug discovery is becoming more expensive and producing less results than ever before (Eroom's Law) —why? One of the ballooning costs is clinical trials. Our co-founder Meri Beckwith sits down with Dr. Mustafa Sultan, creator of The Big Picture Medicine Podcast, to talk through how we're building the anti-CRO (Lindus Health!) to solve this problem.
Discussing the FDA’s latest draft guidances on 510k submissions with M. Jason Brooke, Managing Member at Brooke & Associates
M. Jason Brooke, Attorney and Managing Member at Brooke & Associates, was kind enough to stop by our virtual fireplace to discuss the FDA’s latest draft guidances on 510k submissions and share tips on how medical device companies could best navigate them.